Saturday, October 1, 2022

December 1: Key Developments-Genomics in Mesothelioma Cases

Join us for this complimentary CLE webinar on Thursday, December 1, 2022 from 1:30-2:45 pm ET.
Topics for discussion include:
  • Key Litigation Developments
    • Genomic Data Increasingly Found in Medical Records
    • Dr. Testa’s Acknowledgement that Whole Genome Sequencing is Best and Mutations Cannot Be Predicted
    • Concessions that Some BAP1 Mutations Can By Themselves Cause Mesotheliomas and Other Cancers
    • Developments in Alameda County Regarding Genetic Testing
  • Key Scientific Developments
    • Key Points from Carbone 2022 on BAP1 Null Variants
    • Examples of Null BAP1 Variants in Mesotheliomas
    • Roles of BAP1 Protein
    • Tissue Specific Effects Can Explain the Resulting Cancer(s)
  • Key Applications and Uses of Genomic Data
    • Differences Between WGS and WES
    • Understanding Limits of Gene Panels
    • Uses of Both Somatic and Germline Mutation Data
    • Applications Extend Beyond Mesothelioma.
Title:
Date+Time:
December 1, 2022
1:30-2:45 p.m. ET
Register Now for this free Continuing Legal Education Webinar!
Speakers:
  • Kirk T. Hartley, Principal at LSP Group and ToxicoGenomica
  • Leonel van Zyl, PhD., ToxicoGenomica, CEO, ArrayXpress Inc.
  • Michael Zapata III, Executive Chairman, ArrayXpress, Inc. and Protochips Inc.
CLE Credit:
California, Illinois, New Jersey, New York, Pennsylvania, Texas, and Washington.

By:

No comments:

Post a Comment